COFbenzinga

Tariffs Bite Dan Loeb's Portfolio: Thermo Fisher Hit Hard, Discover Shines

Summary

Year to date, Thermo Fisher fell about 21.03%, both underperforming the iShares U.S. Healthcare ETF, which declined about 2.36%.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 28, 2025 by benzinga